Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort

Background: Research gaps exist on the use of medications for opioid use disorder (OUD) among birthing people. Methods: This retrospective cohort study included people who underwent childbirth deliveries during 2017-2020 and had a diagnosis of OUD identified from a national private insurance claims...

Full description

Bibliographic Details
Main Authors: Xi Wang, Zachary Meisel, Katherine Kellom, Jennifer Whitaker, Douglas Strane, Anyun Chatterjee, Rebecka Rosenquist, Meredith Matone
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Opioid use disorder, Buprenorphine, Medications for opioid use disorder
Pregnancy
Postpartum
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724623000768

Internet

http://www.sciencedirect.com/science/article/pii/S2772724623000768

Similar Items